Assessing benefits in clinical research: why diversity in benefit assessment can be risky.

Larry R. Churchill, Daniel K. Nelson, Gail E. Henderson, Nancy M.P. King, Arlene M. Davis, Erin Leahey, Benjamin S. Wilfond

Research output: Contribution to journalArticle

34 Scopus citations
Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalIRB
Volume25
Issue number3
StatePublished - Jan 1 2003
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Churchill, L. R., Nelson, D. K., Henderson, G. E., King, N. M. P., Davis, A. M., Leahey, E., & Wilfond, B. S. (2003). Assessing benefits in clinical research: why diversity in benefit assessment can be risky. IRB, 25(3), 1-8.